Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Jose Antonio Matute-Briseno"'
1
Hypermetabolic activity by FDG-PET after immunogenic chemotherapy and multi-peptide immunotherapy in ovarian cancer
Autor: Alberto Durazo, Mario Alberto Perez-Astorga, Michelle Antonia Gutierrez-Marquez, Juan Pablo Marquez-Manriquez, Dolores Gallardo-Rincón, Pedro Alejandro Lucero-Diaz, Jose Antonio Matute-Briseno, Alejandro Camacho-Hernandez
Publikováno v: Journal of Clinical Oncology. 37:e17079-e17079
e17079 Background: There are several reports of increased of SUV in the lymph nodes of cancer patients after immune manipulation such as the administration of vaccines and checkpoint inhibitors. However the clinical importance of these phenomena is p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::76ae99c9334cd81f1e3db463a6765b6d
https://doi.org/10.1200/jco.2019.37.15_suppl.e17079
Zobrazit plný text záznamu
2
Induction of immune responses and clinical efficacy in a pilot personalized trial of 26 multi-epitope immunotherapy using long peptides Th1 and CD8 simultaneously in progressive tumors
Autor: Juan P Marquez-Manriquez, JOSE ANTONIO MATUTE-BRISENO, SALVADOR ICEDO-ZAMORA, ALBERTO DURAZO-ACUNA, PEDRO ALEJANDRO Alejandro Lucero-Diaz, MARTIN ORLANDO ROSAS-DELGADO, ALEJANDRO CAMACHO-HERNANDEZ
Publikováno v: The Journal of Immunology. 202:70.17-70.17
Background Most of the immunotherapy trials in progressive cancer are limited targeting few antigens and most of them are not clinically relevant as they are not important for tumor survival. For such reason our approach is to develop multi peptide i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::98dc5498f407ba24194891601faea0f2
https://doi.org/10.4049/jimmunol.202.supp.70.17
Zobrazit plný text záznamu
3
The contribution of tumor type, stage and antigen in the Antibody-Antigen kinetics by ELISA in adult and pediatric cancer patients
Autor: Juan P Marquez-Manriquez, JOSE ANTONIO MATUTE-BRISENO, ALEJANDRO CAMACHO-HERNANDEZ, SALVADOR ICEDO-ZAMORA, PEDRO ALEJANDRO Alejandro Lucero-Diaz
Publikováno v: The Journal of Immunology. 202:131.17-131.17
Background Most of the ELISA studies in cancer patients use different source of antigens, which is mainly limited to recombinant proteins produced in E. coli and this may impact the global results between the studies using even the same antigen becau
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4f81340ec106e4478e28651db7526a15
https://doi.org/10.4049/jimmunol.202.supp.131.17
Zobrazit plný text záznamu
4
Multi-peptide cancer immunotherapy in combination with sorafenib
Autor: Juan P. Marquez-Manriquez, GEOBANNI TORRES MONTANO, MARK L. VERBURG, ALEJANDRO CAMACHO-HERNANDEZ, PEDRO-ALEJANDRO LUCERO-DIAZ, LORENA MONTIJO-FERNANDEZ, PERLA-GABRIELA VILLALOBOS-MOLINA, Simon Hinojosa-Martinez, ALEXIS VERDUGO-VILLASENOR, JOSE-ANTONIO MATUTE-BRISENO
Publikováno v: The Journal of Immunology. 200:122.8-122.8
Background Little is known why most of the cancer immunotherapies failed despite good results in pre-clinical studies. We believe that if we focus on clinically relevant multi-proteins to immune-target simultaneously in combination with drugs with po
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b2144dd19d3e891063308d1f62c139be
https://doi.org/10.4049/jimmunol.200.supp.122.8
Zobrazit plný text záznamu
5
Immunogenicity of diffuse intrinsic pontine glioma (DIPG)
Autor: Juan P. Marquez-Manriquez, Lorena Montijo Fernandez, JOSE ANTONIO MATUTE BRISENO, GEOBANNI TORRES MONTANO, MARK L. VERBURG, ALEJANDRO CAMACHO-HERNANDEZ, PEDRO-ALEJANDRO LUCERO-DIAZ
Publikováno v: The Journal of Immunology. 200:178.23-178.23
Background Little information exists about the potential immunogenicity and immunotargets for DIPG. Most of the pediatric neurotumors are mainly unexplored immunologically. We studied twenty repository samples of DIPG tumors. We selected two relevant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::396c4b7ed8f29088672e075ecdbf3437
https://doi.org/10.4049/jimmunol.200.supp.178.23
Zobrazit plný text záznamu
6
Immune effects of combinatorial repurposing drugs in refractory ovarian and colorectal cancer patients
Autor: Juan P. Marquez-Manriquez, PEDRO-ALEJANDRO LUCERO-DIAZ, LORENA MONTIJO-FERNANDEZ, JOSE-ANTONIO MATUTE-BRISENO, GEOBANNI TORRES MONTANO, MARK L. VERBURG, Martin-Orlando Rosas-Delgado, ALEJANDRO CAMACHO-HERNANDEZ
Publikováno v: The Journal of Immunology. 200:122.7-122.7
Background Some refractory cancer patients have a good Karnofsky despite refractory disease. We studied the potential immunomodulatory properties of approved drugs. We used fresh PBMC from refractory patients to study the immune effects of several dr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b23b9b90679da15f451017a41a2e38f3
https://doi.org/10.4049/jimmunol.200.supp.122.7
Zobrazit plný text záznamu
7
Potential relevant targets in synovial sarcoma
Autor: Pedro Alejandro Lucero-Diaz, Juan Pablo Marquez-Manriquez, Jose Antonio Matute-Briseno, Fernando Alfonso Durazo-Bustamante, Erik Ramos, Mario Alberto Perez-Astorga, Tania E Gandara-Marti, Mark Verburg, Jorge Martinez Tlahuel
Publikováno v: Journal of Clinical Oncology. 34:e22527-e22527
e22527Background: The potential clinical important targets for synovial sarcoma (SS) are mainly unknown. We performed a systematic review and we found eight potential proteins to be targeted in thi...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f3d18cac340dce0f16ee8658492e6ef
https://doi.org/10.1200/jco.2016.34.15_suppl.e22527
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje